Genome-Wide Analysis Identifies and As Novel Notch1 Transcriptional Targets in Thymocytes
Overview
Affiliations
Recombination activating genes 1 () and are expressed in immature lymphocytes and essential for generating the vast repertoire of antigen receptors. Yet, the mechanisms governing the transcription of and remain to be fully determined, particularly in thymocytes. Combining cDNA microarray and ChIP-seq analysis, we identify and as novel Notch1 transcriptional targets in acute T-cell lymphoblastic leukemia (T-ALL) cells. We further demonstrate that Notch1 transcriptional complexes directly bind the and locus in not only T-ALL but also primary double negative (DN) T-cell progenitors. Specifically, dimeric Notch1 transcriptional complexes activate and through a novel -element bearing a sequence-paired site (SPS). In T-ALL and DN cells, dimerization-defective Notch1 causes compromised and expression; conversely, dimerization-competent Notch1 achieves optimal upregulation of both. Collectively, these results reveal Notch1 dimerization-mediated transcription as one of the mechanisms for activating and expression in both primary and transformed thymocytes. Our data suggest a new role of Notch1 dimerization in compelling efficient TCRβ rearrangements in DN progenitors during T-cell development.
T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy.
Kalinina A, Khromykh L, Kazansky D Int J Mol Sci. 2023; 24(20).
PMID: 37894892 PMC: 10607890. DOI: 10.3390/ijms242015211.
Ehm P, Rietow R, Wegner W, Bussmann L, Kriegs M, Dierck K Cells. 2023; 12(13).
PMID: 37443832 PMC: 10341211. DOI: 10.3390/cells12131798.
Srinivasan J, Vasudev A, Shasha C, Selden H, Perez Jr E, LaFleur B Aging Cell. 2023; 22(8):e13870.
PMID: 37221658 PMC: 10410006. DOI: 10.1111/acel.13870.
Established and Emerging Methods for Protecting Linear DNA in Cell-Free Expression Systems.
Fochtman T, Oza J Methods Protoc. 2023; 6(2).
PMID: 37104018 PMC: 10146267. DOI: 10.3390/mps6020036.
Lymphoid cell development from fetal hematopoietic progenitors and human pluripotent stem cells.
Sun S, Wijanarko K, Liani O, Strumila K, Ng E, Elefanty A Immunol Rev. 2023; 315(1):154-170.
PMID: 36939073 PMC: 10952469. DOI: 10.1111/imr.13197.